Suitors Weigh Bids for Sanofi's $3B European Generics Biz Post author:Sam Post published:January 10, 2018 Post category:BioPharma The portfolio consists of acute, chronic and oncology products. Source: BioSpace You Might Also Like Germany's Novaliq Sets Up U.S. Subsidiary in Cambridge, Massachusetts January 8, 2018 Perrigo Unveils Sale of Two Business Units August 10, 2017 Meet This Largely Over-Looked Phase 3 Alzheimer's Company January 30, 2017
